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MLKL is crucial for necroptosis, permeabilizing
membranes through its N-terminal region upon
phosphorylation of its kinase-like domain by RIP3.
However, the mechanism underlying membrane per-
meabilization is unknown. The solution structure of
the MLKL N-terminal region determined by nuclear
magnetic resonance spectroscopy reveals a four-he-
lix bundle with an additional helix at the top that is
likely key for MLKL function, and a sixth, C-terminal
helix that interacts with the top helix and with a
poorly packed interface within the four-helix bundle.
Fluorescence spectroscopy measurements indicate
that much of the four-helix bundle inserts into mem-
branes, but not the C-terminal helix. Moreover, we
find that the four-helix bundle is sufficient to induce
liposome leakage and that the C-terminal helix in-
hibits this activity. These results suggest that the
four-helix bundle mediates membrane breakdown
during necroptosis and that the sixth helix acts as a
plug that prevents opening of the bundle and is
released upon RIP3 phosphorylation.
INTRODUCTION
Cell death triggered by defined biochemical pathways plays crit-
ical roles in normal tissue development as well as in diverse path-
ological processes (Fiers et al., 1999). Apoptosis and necrosis
constitute the two major forms of cell death caused by these
pathways, and are characterized by distinct morphological and
biochemical alterations. Apoptosis is a process of programmed
cell death that results in structural changes such as nuclear
membrane collapse, chromatin fragmentation, cell condensa-
tion, and break down into small vesicles called apoptotic bodies,
which are promptly eliminated by phagocytosis (Kerr et al.,
1972). The molecular events leading to apoptosis have been
exquisitely well characterized. A key step is the activation of
cysteine proteases known as caspases (Thornberry and Lazeb-
nik, 1998), which can be induced extrinsically by cytokines from
the tumor necrosis factor (TNF) family and intrinsically by mem-
bers of the Bcl-2 family of proteins such as Bax (Danial and
Korsmeyer, 2004). These proteins can form oligomeric pores inStructure 22, 1489–membranes (Epand et al., 2002) and permeabilize mitochondria
(Wei et al., 2001; Kuwana et al., 2002), causing the release into
the cytosol of factors such as cytochrome c that are crucial for
downstream events leading to caspase activation (Li et al.,
1997).
Necrosis is characterized by cellular swelling, rupture of the
plasma membrane, and release of the cellular components to
the extracellular space (Laster et al., 1988; Proskuryakov et al.,
2003). Whereas necrosis was initially considered a passive
form of cell death resulting, for instance, from extreme cellular
stress, it has become clear that necrosis can be induced in a
regulated manner by certain physiological or pathophysiological
stimuli (Proskuryakov et al., 2002), and viral or chemical inhibi-
tors of caspases cause an increase in necrotic cell death (Ver-
cammen et al., 1998; Cho et al., 2009). This form of programmed
necrotic death, called necroptosis, is believed to provide a
mechanism to defend against pathogens that suppress
apoptosis (Vandenabeele et al., 2010; Vanlangenakker et al.,
2012) and participates at least in part in diseases involving acute
tissue damage such as terminal ileitis, systemic inflammatory
response, and ethanol-induced liver injury (Duprez et al., 2011;
Gu¨nther et al., 2011; Roychowdhury et al., 2013). Moreover, in
a recent study, we showed that necroptosis is activated in liver
biopsy samples of patients with drug-induced liver injury
(Wang et al., 2014). Hence, understanding the molecular path-
ways underlying necroptosis can provide novel therapeutic op-
portunities for a wide variety of devastating diseases.
Necroptosis requires receptor-interacting kinase 1 (RIP1)
(Holler et al., 2000; Degterev et al., 2008), which also plays an
important role in TNF-induced apoptosis (Festjens et al., 2007;
Wang et al., 2008). The key factor that switches TNF-induced
cell death from apoptosis to necrosis is the RIP1-related kinase
RIP3 (Cho et al., 2009; He et al., 2009; Zhang et al., 2009). During
necroptosis, RIP3 interacts with RIP1 to recruit the downstream
effector mixed-lineage kinase domain-like (MLKL) protein to
form the necrosome, within which MLKL becomes phosphory-
lated at Threonine 357 and Serine 358 (Sun et al., 2012; Wang
et al., 2014). The functional importance of MLKL was empha-
sized by the finding that a small molecule called necrosulfona-
mide (NSA) specifically blocks necroptosis downstream of
RIP3 activation by covalently reacting with Cys86 of human
MLKL (Sun et al., 2012).
To elucidate how MLKL causes necroptosis, we investigated
its biochemical and structural properties, and amolecular under-
standing of MLKL function has started to emerge from data that
we present in our separate study (Wang et al., 2014) as well as1500, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1489
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Figure 1. MLKL(2–154) Forms an Autonomously Folded Domain
The contour plots show superimposed 1H-15N HSQC spectra of MLKL(2–154)
(black contours) and MLKL(2–178) (red contours).
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Mechanism of Membrane Permeation by MLKLfrom results reported by other groups during the course of our
work. The crystal structure of mouse MLKL has shown that this
protein comprises a C-terminal kinase-like domain that contains
an unusual pseudoactive site near the RIP3 phosphorylation site
and is tethered to an N-terminal four-helix bundle through a con-
necting a helix, although the region harboring the residue homol-
ogous to C86 of humanMLKLwas not observable (Murphy et al.,
2013). We and others found that MLKL oligomerizes and translo-
cates to membranes (Cai et al., 2014; Chen et al., 2014; Wang
et al., 2014). However, although this event was proposed to
mediate localization of MLKL to the plasma membrane and to
induce Ca2+ influx (Cai et al., 2014) or Na+ influx, thus increasing
osmotic pressure and eventually causing membrane rupture
(Chen et al., 2014), we found that phosphorylatedMLKL localizes
not only to the plasma membrane but also to internal mem-
branes, and that the MLKL N-terminal region binds directly to
phospholipids and induces membrane permeabilization (Wang
et al., 2014). These findings suggest that necrotic cell death re-
sults from disruption of multiple membranes by the MLKL N-ter-
minal region upon phosphorylation of the MLKL kinase-like
domain by RIP3. However, the molecular mechanism underlying
membrane permeation by MLKL remains unclear.
The study presented here was designed to dissect how
different structural elements of the MLKL N-terminal region
contribute to MLKL function. We determined the solution struc-
ture of the MLKL N-terminal region by nuclear magnetic reso-
nance (NMR) spectroscopy and found a similar architecture to
that observed in the crystal structure of MLKL, with a four-helix
bundle bound to a C-terminal helix, but with an additional a helix
that includes C86 and also contacts the C-terminal helix at the
top of the domain. Fluorescence experiments with the environ-
ment sensitive probe 7-nitrobenz-2-oxa-1,3-diazole (NBD) and
liposome leakage assays reveal that the four-helix bundle is
responsible for membrane insertion and membrane permeabili-
zation, while the C-terminal helix inhibits this activity. Our
results suggest a model whereby opening of the four-helix
bundle at a site where two helices are poorly packed exposes
the hydrophobic interior to enable membrane insertion, and the
C-terminal helix acts as a plug that hinders such opening and
couples allosteric changes caused by RIP3 phosphorylation on
the kinase-like domain to activate membrane permeation by
MLKL.
RESULTS
Residues 2–154 of MLKL Form an Autonomously
Folded Module
Secondary structure predictions suggested that human MLKL
contains a helical region from residues 1 to 178. In a separate
study, we showed that a minimal fragment spanning this region
(residues 2–178) binds to membranes containing polyacidic
phospholipids such as phosphatidylinositol 4,5-bisphosphate
(PIP2), a component of the plasma membrane, or cardiolipin, a
component of the mitochondrial membranes (Wang et al.,
2014). To further study the biochemical and structural properties
of the N-terminal helical region ofMLKL, we first tried to identify a
minimal folded domain. For this purpose, we acquired 1H-15N
heteronuclear single quantum coherence (HSQC) spectra of
MLKL(2–178) and a shorter fragment ending at residue 1541490 Structure 22, 1489–1500, October 7, 2014 ª2014 Elsevier Ltd A(MLKL[2–154]) that could also be expressed in soluble form.
1H-15NHSQC spectra can be considered like protein fingerprints
with one cross-peak for each non-proline residue in a 15N-
labeled protein, and provide a powerful tool to assess the folding
of the protein from the dispersion of the cross-peaks, as well as
to study interactions with a target molecule(s) from the perturba-
tions in the fingerprints caused by the target molecule (Rizo et al.,
2012). The 1H-15N HSQC spectrum of MLKL(2–154) was of high
quality and exhibited excellent dispersion (Figure 1, black con-
tours), as expected for a monomeric, well-folded domain. The
1H-15N HSQC spectrum of MLKL(2–178) was similar, with well-
resolved cross-peaks that were in the same positions observed
for MLKL(2–154) but had broader line widths, and additional
cross-peaks in the center of the spectrum (Figure 1, red con-
tours). A few of the cross-peaks from residues 2 to 154 were
shifted and/or strongly broadened in MLKL(2–178) but, based
on the resonance assignments obtained for structure determina-
tion (see below), these cross-peaks correspond to residues that
are located near residue 154 (Figure S1 available online). Hence,
the perturbations in these cross-peaks can be attributed to prox-
imity to the additional C-terminal residues in MLKL(2–178) and
do not arise from overall conformational changes. These results
show that MLKL(2–154) forms a monomeric autonomously
folded domain in solution, that MLKL(2–178) has a higher ten-
dency to aggregate, and that the additional C-terminal residues
in MLKL(2–178) are largely unstructured in the context of this
longer fragment.
MLKL(2–154) Causes Permeabilization of
Cardiolipin-Containing Membranes
To test whether MLKL(2–154) binds to membranes containing
cardiolipin, as described for MLKL(2–178) (Wang et al., 2014),ll rights reserved
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Figure 2. MLKL(2–154) Binds to Liposomes
but Not to Nanodiscs
1H-15N TROSY-HSQC spectra of MLKL(2–154) in
the absence (black contours) and presence (red
contours) of nanodiscs (A) or liposomes (B) con-
taining 45% POPC, 30% POPE, 10% PI, and 15%
cardiolipin. The one-dimensional traces shown
above the 2D contour plots were taken at the 15N
chemical shift indicated by the blue arrows and
illustrate how the cross-peak intensities were not
significantly affected by the nanodiscs but were
strongly decreased by the liposomes.
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Mechanism of Membrane Permeation by MLKLwe performed cofloatation assays with liposomes containing
2%, 5% and 15% cardiolipin. Note that the larger percentages
of cardiolipin correspond with those present in mitochondrial
membranes (Getz et al., 1962). We observed increased binding
of the MLKL(2–154) to liposomes with increasing amounts
of cardiolipin and liposome binding was concomitant with the
formation of MLKL(2–154) oligomers under the nonreducing
conditions used in these experiments (Figure S2). This finding
suggested that disulfide bond formation contributed to MLKL
(2–154) oligomerization, although it may also arise from the
confinement of the protein on the membranes.
To study how MLKL(2–154) binds to membranes, we attemp-
ted to use nanodiscs, which are self-assembled disc-like phos-
pholipid bilayers surrounded by amembrane scaffolding protein.
Because nanodiscs of relatively small sizes (e.g., 10–12 nm) can
be obtained by using appropriate fragments of apolipoprotein A1
(Denisov et al., 2004), they provide a powerful tool to analyze
proteins in membrane environments by NMR spectroscopy us-
ing transversed relaxation optimized (TROSY)-based experi-
ments (Shenkarev et al., 2009; Brewer et al., 2011; Hagn et al.,
2013). Intriguingly, addition of nanodiscs containing 15% cardi-
olipin did not cause any significant changes in the positions and
intensities of the 1H-15N TROSY-HSQC cross-peaks of MLKL(2–
154), whereas strong decreases in cross-peak intensities were
observed upon addition of liposomes with the same phospho-
lipid composition (compare black and red contours in the 2D
plots and the one-dimensional traces shown in Figures 2A and
2B). The latter result was expected because liposome binding
should result in broadening of the cross-peaks beyond detection
(the residual observable signals can be attributed to residual
MLKL[2–154] that remains unbound because of membrane satu-
ration). Conversely, the absence of any effects of the nanodiscs
on the 1H-15N TROSY-HSQC spectrum of MLKL(2–154) is sur-
prising and indeed remarkable, since these spectra are very sen-
sitive to even a small amount of binding to large species such as
nanodiscs (Rizo et al., 2012), and shows that there is no detect-
able binding of MLKL(2–154) to nanodiscs even at the total lipid
concentrations used in these experiments (1 mM).Structure 22, 1489–1500, October 7, 2014 ªThe finding that MLKL(2–154) binds to
liposomes but not to nanodiscs sug-
gested that phospholipid binding does
not reflect merely a surface interaction
but rather involves insertion of at least
part of MLKL(2–154) into the phospho-
lipid bilayer, and such insertion is pre-vented in nanodiscs because a large number of lipids would
need to displaced within the constraints imposed by the scaf-
folding protein to make room for MLKL(2–154). This effect
against insertion into nanodiscs is expected to be compounded
by formation of MLKL(2–154) oligomers (Figure S2; see also
Wang et al., 2014). These observations, and the fact that other
protein domains that are highly soluble in solution but oligomer-
ize within membranes can form membrane pores (e.g., Mukher-
jee et al., 2014), led us to hypothesize that MLKL may permeabi-
lize membranes. Indeed, we found that MLKL causes liposome
leakiness, that mutations mimicking phosphorylation by RIP3
enhance this activity, and that leakiness is caused by MLKL(2–
178) but not by the MLKL kinase-like domain (Wang et al.,
2014). In the context of the present study, we tested whether
the smaller MLKL(2–154) fragment is sufficient to cause lipo-
some leakiness using a sulforhodamine B de-quenching assay.
We found that MLKL(2–154) induces liposome leakiness in a
dose-dependent, saturable manner, with a half-maximal effec-
tive concentration (EC50) of 140 nM under the conditions of our
experiments (Figure 3). At concentrations on the 150 nM range,
MLKL(2–154) did not cause an increase in vesicle size (Fig-
ure S3), indicating that leakiness does not arise from large mem-
brane rearrangements leading to fusion. This result correlates
with the finding that the pores induced in liposomes byMLKL un-
der similar conditions are permeablemostly tomolecules smaller
than 10 kDa, although increasingly larger molecules permeate
with high MLKL concentrations (Wang et al., 2014).
Solution Structure of MLKL(2–154)
Our results and the prediction that MLKL(2–154) contains multi-
ple a helices suggested that the mechanism of action of the
MLKL N-terminal domain might resemble that of proteins from
the Bcl-2 family of proteins such as Bax, which contain soluble
helical domains that insert into membranes and permeabilize
them (Epand et al., 2002; Wei et al., 2001; Kuwana et al., 2002).
To investigate whether the architecture of MLKL(2–154) is similar
to that of Bcl-2 proteins, we attempted to crystallize this MLKL
fragment but very limited precipitation was observed in a variety2014 Elsevier Ltd All rights reserved 1491
A B Figure 3. MLKL(2–154) Causes Membrane
Leakiness
(A) Liposome leakage assays monitoring the de-
quenching of sulforhodamine B fluorescence as a
function of time in the presence of difference
concentrations of MLKL(2–154) (color-coded and
indicated on the right in micromolar concentra-
tions). The protein was added after 200 s. The data
were normalized with the fluorescence observed
after adding detergent, and setting at zero the
fluorescence right before protein addition.
(B) Plot of the fluorescence intensity observed af-
ter 1,700 s (expressed as percent of the maximum)
as a function of MLKL(2–154) concentration. The
curve shows the fit to a Hill equation, which yielded
an EC50 of 140 nM and a Hill coefficient of 1.5.
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Mechanism of Membrane Permeation by MLKLof screens even at a protein concentration of 100mg/ml, showing
that the fragment is highly soluble. Hence, we determined the 3D
structure of MLKL(2–154) in solution using NMR spectroscopy.
Final structures were calculated using 2,864 experimentally
derived restraints. The structural statistics are summarized in Ta-
ble 1, and Figure 4A shows a backbone superposition of the 20
structures with the lowest NOE energies. The superposition
shows that the structure is well defined throughout much of
MLKL(2–154). At the outset, the availability of the crystal structure
of mouse MLKL that was recently reported (Murphy et al., 2013)
allowed us comparison of our solution structure of the isolated
N-terminal domain with the structure of this domain in the context
of the crystals of full-length MLKL. A sequence alignment of
MLKL N-terminal domains from different species is shown in Fig-
ure S4 to facilitate assessment of the degree of evolutionary con-
servation of residues discussed below.
The solution structure of MLKL(2–154) revealed six a helices
that we will refer to as H1–H6 (Figures 4A and 4B). Helices H1,
H2, H3, and H5 form a four-helix bundle that packs against the
C-terminal helix (H6) at the top half of the domain (in the orienta-
tion of Figure 4B). This architecture is similar to that observed for
the N-terminal domain in the crystal structure of mouse MLKL
but, apart from some differences in the packing of the helices
that are discussed below, a clear difference between the two
structures is the presence of helix H4 at the top of the domain
in our solution structure (Figures 4B and 4C). This helix contains
C86, the cysteine that constitutes the target of NSA to block nec-
roptosis (Sun et al., 2012), but no density is observable for the
corresponding sequence in the crystal structure of mouse
MLKL (Figure 4C; Murphy et al., 2013). The structural super-
position of Figure 4D shows that steric clashes between H4
and the kinase-like domain would occur if helix H4 were formed
in the context of the crystal structure. These observations sug-
gest that steric clashes prevent formation of helix H4 in the
conformation observed in the crystals and that there is an inti-
mate interplay between the orientation of the kinase-like domain
and the structure of the N-terminal domain, particularly at the top
of the domain.
The Four-Helix Bundle of MLKL(2–154) Mediates
Membrane Insertion
To explore whether membrane insertion involves large changes
in secondary structure, we acquired circular dichroism (CD)1492 Structure 22, 1489–1500, October 7, 2014 ª2014 Elsevier Ltd Aspectra of MLKL(2–154) in the absence and presence of lipo-
somes (Figure S5A). The CD spectrum of free MLKL(2–154)
was characteristic of a highly a-helical protein, as expected.
The addition of lipsomes caused only small changes, indicating
that the protein remains highly a-helical upon membrane inser-
tion, but this finding does not exclude the possibility of large
changes in tertiary structure.
To gain further insights into how MLKL(2–154) inserts into
membranes, we designed an approach that takes advantage
of the high sensitivity of the fluorescent probe 7-nitrobenz-2-
oxa-1,3-diazole (NBD) to its environment, exhibiting large in-
creases when the probe is transferred from aqueous solution
to a hydrophobic milieu (Crowley et al., 1993; Arac¸ et al.,
2006). The approach is also based on the finding that DTT
impaired the liposome-leaking activity of MLKL(2–154) only to
a small extent (Figure S5B), indicating that cysteines are not
crucial for this activity. Hence, we created single cysteine ver-
sions of MLKL(2–154) by mutating the four native cysteines to
serines, and then introducing cysteines in strategic positions of
the different helices that are solvent exposed in the structure of
MLKL(2–154). Below, we will refer to these mutants naming
only the residue that was mutated to cysteine (e.g., T9C for the
mutant with all native cysteines mutated to serine and Thr9
mutated to cysteine). We also prepared one MLKL(2–154)
mutant where we retained the native cysteine C86, which is
located in helix H4, and mutated the other three native cysteines
to serines (referred to as C86 mutant). All mutant proteins were
labeled with NBD and their fluorescence spectra were recorded
in the absence and presence of liposomes (Figure 5). The wave-
lengths of the fluorescence maxima observed, their intensities,
and the ratios between the maximum intensities in the absence
and presence of liposomes (r) are listed in Table 2. All NBD-
labeled proteins were able to induce liposomes leakiness albeit
to different extents (Figures S5C and S5D). Thus, although the
different activities in the leakiness assay may reflect differential
effects of the mutations on the structure and/or oligomerization
propensity of membrane-bound MLKL(2–154), all mutants re-
mained functional to some degree.
Six of the mutants (T9C, V13C, H33C, T60C, D100C, and
D107C) exhibited low NBD fluorescence intensities in the
absence of liposomes and large intensity increases upon lipo-
some binding (Figures 5A–5C, 5E, 5H, and 5I), with intensity ratio
r ranging from 3.6 to 5.0 (Table 2; see residues colored in red inll rights reserved
Table 1. Structural Statistics for the 20 Simulated Annealing
Structures of the MLKL N-Terminal Domain with the Lowest NOE
Energies
Average Rmsds from Experimental Restraints (2,864 Total)
NOE distance restraints (A˚)
All 2,498 0.012 ± 0.0002
Intraresidue 324 0.010 ± 0.0011
Sequential (ji-jj = 1) 475 0.009 ± 0.0008
Short range (ji-jj = 2-4) 923 0.014 ± 0.0004
Long range (ji-jj > 4) 776 0.012 ± 0.0004
Hydrogen bonds (A˚) 134 0.008 ± 0.0010
Dihedral angles (

) 232 0.105 ± 0.017
Average Rmsd from Idealized Covalent Geometry
Bonds (A˚) 0.0021 ± 0.0004
Angles (

) 0.41 ± 0.007
Impropers (

) 0.30 ± 0.006
Ramachandran Plot Statistics (%)a
Residues in most favored regions 86.1
Residues in additionally allowed regions 12.2
Residues in generously allowed regions 1.2
Residues in nonallowed regions 0.5
Average Rmsd of Atomic Coordinates (A˚)
Backbone residues (2–150) 0.48
Heavy-atom residues (2–150) 1.31
Backbone secondary structureb 0.46
Heavy-atom secondary structureb 1.20
rmsd, root-mean-square deviation.
aCalculated using the program PROCHECK.
bSix a helices, residues 2–20, 25–47, 56–80, 82–91, 99–120, 133–150.
Figure 4. Structure of MLKL(2–154) in Solution
(A) Backbone superposition of the 20 NMR structures of MLKL(2–154) with
the lowest NOE energies. The six a helices are labeled H1–H6 and corre-
spond to residues 2–20 (H1), 25–47 (H2), 56–80 (H3), 82–91 (H4), 99–120
(H5), and 133–150 (H6). N and C indicate the N- and C-termini, respec-
tively.
(B) Ribbon diagram of the solution structure of MLKL(2–154). The helices that
form the four-helix bundle are colored in blue, the helix in the top that contains
C86 (helix H4) in yellow, and the C-terminal helix (H6) in red. The positions of
selected residues are indicated to help identifying the locations of residues
discussed in the text within the structure.
(C) Superposition of ribbon diagrams of the solution structure of MLKL(2–154)
(blue) and the crystal structure of mouse MLKL (orange; Protein Data Bank
accession code 4BTF; Murphy et al., 2013). The atoms of the residue of the
kinase-like domain of mouse MLKL that is phosphorylated by RIP3 (S345) are
shown as spheres and colored in green.
(D) Close-up of the interface between the kinase-like domain and the N-ter-
minal helical domain in the structural superposition shown in (C); also showing
the proteins as stick models. The red ellipses show areas where helix H4,
which is observed in our solution structure but is not observed in the crystal
structure, would have steric clashes with the kinase-like domain in the relative
orientation between the two domains observed in the crystal structure.
Selected residues involved in the clashes are labeled.
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Mechanism of Membrane Permeation by MLKLFigure 5L). This behavior is expected for NBD probes that are
exposed to the aqueous millieu in monomeric soluble MLKL(2–
154) but are transferred into a hydrophobic environment upon
lipid binding, either because they are in direct contact with the
acyl chains of the bilayers or because they become buried within
new intramolecular or intermolecular helix-helix interfaces
formed in the membrane-bound oligomer. The L114C mutant
(colored in yellow in Figure 5L) also had a low NBD fluorescence
intensity in the absence of lipids but underwent a considerably
lower increase in intensity upon lipid binding (Figure 5J), indi-
cating that the probe occupies a more interfacial location of
the bilayer. Three of the mutants (M44C, A67C, and C86) ex-
hibited higher fluorescence intensities in the absence of lipids
than expected for an aqueous environment (Figures 5D,
5F,and 5G), suggesting that the NBD probe already experiences
a somewhat hydrophobic environment in soluble MLKL(2–154)
due to packing with neighboring side chains. Nevertheless, in-
creases in NBD fluorescence intensities were also observed for
these three mutants (residues colored in orange in Figure 5L).
Therefore, the NBD probes in these mutants may also become
in contact with the lipids or may be buried within the protein
upon membrane binding. Finally, a low NBD fluorescence inten-
sity was observed for the Q139C mutant in the absence and
presence of liposomes (Figure 5K; residue colored in gray in Fig-
ure 5L), showing that the probe remains an aqueous environmentStructure 22, 1489–1500, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1493
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Figure 5. The MLKL Four-Helix Bundle Is Responsible for Membrane Insertion
(A–K) NBD fluorescence spectra of the indicated MLKL(2–154) mutants in the absence (black) and presence (red) of liposomes containing 15% cardiolipin.
(L) Ribbon diagram of the solution structure of MLKL(2–154) summarizing the NBD fluorescence results shown in (A–K). The side chain of C86 and of residues that
were replaced with cysteine and labeled with NBD are shown as spheres, labeled with the residue number and color coded: red indicates low NBD fluorescence
in the absence of liposomes and strong increase in intensity upon addition of liposomes, orange indicates stronger than usual NBD fluorescence in the absence of
liposomes (which increased further upon liposome addition), yellow indicates low NBD fluorescence in the absence of liposomes and a moderate increase upon
liposome addition, and gray denotes low NBD fluorescence in the absence and presence of liposomes.
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Mechanism of Membrane Permeation by MLKLeven upon binding of MLKL(2–154) to the lipids. While the indi-
vidual results obtained for each mutant need to be interpreted
with caution because of the potential effects that the mutations
or NBD labelingmight have on the structure ofmembrane-bound
MLKL(2–154), the overall NBD fluorescence data (summarized in
Figure 5L) indicate that much of the four-helix bundle formed by
helices H1, H2, H3, and H5 is involved in membrane insertion,
whereas the C-terminal helix H6 is not.
Inhibition of Membrane Permeabilization Activity by
Helix H6 and NSA
To further understand the results obtained in the NBD fluores-
cence experiments and the mechanism of membrane permeabi-
lization by MLKL(2–154), we examined the packing between the
a helices in our solution structure. Interestingly, we found that the
helical pairs H1-H2, H1-H3, and H3-H5 are well packed (Figures
6A–6C), as is common in a well-folded domain, but helices H21494 Structure 22, 1489–1500, October 7, 2014 ª2014 Elsevier Ltd Aand H5 are not well packed against each other and are more
distant from each other than is common in neighboring helices
(compare Figure 6D with Figures 6A–6C). This observation
does not arisemerely from a lack of NOE data to define the pack-
ing in this region of the domain, which can occur in structure
determination by NMR spectroscopy (Lu et al., 2002), because
the separation between helices H2 and H5 is very similar in our
NMR structure of human MLKL(2–154) and the X-ray structure
of mouse MLKL (Figure 6E), and the packing between these
two helices is also less than optimal in the crystal structure (Fig-
ure S6A). We did observe some overt differences in the orienta-
tion of some conserved side chains such as W109 (W108 in
mouse MLKL) in the interface between helices H2 and H5 (Fig-
ure 6E), and these differences do not arise from a poor definition
of the NMR structure, since the orientation of the W109 side
chain is defined by a large number of long-range NOEs (e.g., Fig-
ures S6B and S6C). We also observed some differences in thell rights reserved
Table 2. Fluorescence Changes upon Liposome Binding for NBD
Labels Placed at Different Positions of MLKL(2–154)
Residue
lmax
 Lipidsa
Imax
 Lipidsb
lmax
+ Lipidsa
Imax
+ Lipidsb rc
T9C 548 0.32 537 1.34 4.2
V13C 547 0.24 532 1.20 5.0
H33C 546 0.31 534 1.39 4.5
M44C 551 1.10 536 1.56 1.4
T60C 548 0.29 539 1.05 3.6
A67C 557 0.72 536 1.22 1.7
C86 542 1.42 535 1.85 1.3
D100C 551 0.24 533 1.05 4.4
D107C 550 0.26 536 1.11 4.3
L114C 552 0.24 539 0.61 2.5
Q139C 551 0.18 546 0.12 0.7
aIn nanometers. Estimated error ± 2 nm for the NBD labels with stronger
fluorescence intensities and ± 3 nm for those with smaller intensities.
bIn arbitrary units. Values represent averages from at least five measure-
ments. SDs range from 3% to 7%.
cThe ratio r is defined as (Imax + lipids)/(Imax  lipids).
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Mechanism of Membrane Permeation by MLKLmode of packing of helix H6 against helix H2, and in the overall
orientation of helix 6, when comparing the NMR and X-ray struc-
tures, despite the fact that the side chains in the interface are
generally conserved (Figures 6F and 6G).
The picture that emerges from these observations is that the
structure of MLKL(2–154) is somewhat unusual for a globular
protein domain because some of the neighboring elements of
secondary structure are not well packed. In particular, the inter-
face between helices H2 and H5 appears to be malleable due to
the poor packing and therefore offers a natural place where the
structure of the four-helix bundle can ‘‘open’’ and expose its hy-
drophobic interior to favor membrane insertion and oligomeriza-
tion. Such oligomerization likely allows formation of pores lined
by the abundant charges on the surface of the four-helix bundle,
since it would be energetically unfavorable to bury such
charged residues in the hydrophobic interior of the bilayer. In
this model, the intramolecular interactions of helix H6 with heli-
ces H2 and H5 would stabilize the monomeric, water-soluble
structure to hinder membrane insertion, and alteration of these
interactions by phosphorylation of MLKL would play a key role
in the mechanism of activation of its membrane permeabiliza-
tion function.
To test our model, we prepared a shorter MLKL fragment
spanning the four-helix bundle [MLKL(2–123)]. Although this
fragment could be expressed efficiently in bacteria in a soluble
and monomeric form (as judged by gel filtration), its 1H-15N
HSQC spectrum exhibited broader and considerably fewer
well-resolved cross-peaks than that of MLKL(2–154) (Fig-
ure S7A), and we also observed a tendency to degradation.
These findings are consistent with the notion that the structure
of MLKL(2–123) is not very stable. Moreover, we found that
MLKL(2–123) is much more active than MLKL(2–154) in inducing
liposome leakage (Figure 7A; compare red and black curves),
strongly supporting the notion that the four-helix bundle is
responsible for this activity. To further test our model, we pre-
pared a double mutant of MLKL(2–154) in which two basic resi-Structure 22, 1489–dues of helix H2 (K26 and R30; see Figure 7B), which form salt
bridges with acidic residues of helix H6 (Figure 6F) and hence
are likely to stabilize the H2–H6 interface, were mutated to gluta-
mate (K26E,R30E mutant). As expected, this mutation increased
the activity ofMLKL(2–154) in inducing liposome leakage consid-
erably (Figure 7A, green curve), albeit not as much as truncation
of the entire H6 helix. The specificity of this effect was shown by
the observation that the liposome leakage activity was impaired
by neutralizing K22 and K25, two basic residues that are at the
top of the four-helix bundle, near K26 and R30 (Figure 7B), but
do not participate in interactions with helix H6 (Figure 7A, blue
curve). Cofloatation assays showed that MLKL(2–123) and the
MLKL(2–154) K26E,R30E and K22Q,K25Q mutants bind to lipo-
somes to similar extents that appeared to be somewhat lower
than that of wild-type (WT) MLKL(2–154) (Figure S7B). Hence,
while the impaired activity of the K22Q,K25Q mutant in the
leakage assay may arise from partial disruption of lipid binding,
consistent with the importance of polyacidic head groups for
binding of MLKL to phospholipids (Wang et al., 2014), the
increased leakage activities of MLKL(2–123) and the MLKL(2–
154) K26E,R30E do not arise from enhanced lipid binding.
We also tried tomutate helix 6 inMLKL(2–154) to disrupt its inter-
action with the four-helix bundle, but unfortunately all mutations
attempted (D140K; E136K,D140K; E136Q,D140K; and E136Q,
D140Q,E134Q) yielded proteins with a high tendency to degra-
dation and/or aggregation.
In a final set of experiments, we tested whether NSA affects
the liposome leakage activity of MLKL(2–154), because the inhi-
bition of necroptosis by this small compound was key for the dis-
covery of the functional importance of MLKL (Sun et al., 2012).
Preincubation of MLKL(2–154) with NSA markedly inhibited its
ability to induce liposome leakage, as we observed in experi-
ments performed with full-length MLKL (Wang et al., 2014),
and NSA by itself did not cause liposome leakage (Figure 7C).
Hence, these leakage assays with the N-terminal helical domain
of MLKL appear to recapitulate at least to some extent the inhi-
bition of MLKL function caused by NSA in cells.
DISCUSSION
Necroptosis has emerged as an important form of programmed
cell death that is alternative to apoptosis and is implicated inmul-
tiple human diseases. While the molecular basis of apoptosis
has been exquisitely well characterized, the mechanisms under-
lying necroptosis are just being discovered. It is now well estab-
lished that RIP3 is key for commitment of cells to necroptosis
(Cho et al., 2009; He et al., 2009; Zhang et al., 2009) and that
MLKL constitutes a critical downstream target of RIP3 (Sun
et al., 2012). In addition, MLKL was recently found to oligomer-
ize, translocating to membranes (Cai et al., 2014; Chen et al.,
2014; Wang et al., 2014), and our recent study showed that
MLKL permeabilizes membranes through the N-terminal helical
domain upon phosphorylation by RIP3 (Wang et al., 2014).
Because a key characteristic of necroptosis is the breakdown
of cellular membranes, membrane permeabilization by MLKL
most likely constitutes the key event that is triggered by the sig-
nals that lead to necroptosis. It is thus crucial to understand how
such permeabilization occurs. To address this question, we have
determined the solution structure of the MLKL N-terminal region1500, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1495
Figure 6. Analysis of Packing between Helices in MLKL(2–154)
(A–D) Ribbon diagrams (left) and space filling models (right) of the four pairs of neighboring helices in the four-helix bundle. The helical pairs are oriented with their
polar surface in front. The atoms of the side chains of basic residues are colored in blue and those of acidic side chains are colored in red. In other side chains and
(legend continued on next page)
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Figure 7. The MLKL Four-Helix Bundle Is Sufficient to Induce Liposome Leakiness and Helix H6 Inhibits This Activity
(A) Liposome leakage assays monitoring the de-quenching of sulforhodamine B fluorescence as a function of time in the presence of WT MLKL(2–154) (black
curve), MLKL(2–154) K26E,R30E mutant (green curve), MLKL(2–154) K22Q,K25Q mutant (blue curve), and MLKL(2–123) (red).
(B) Ribbon diagram of MLKL(2–154) showing the side chains of the mutated residues as spheres (dark blue for K22 and K25; lighter blue for K26 and R30).
(C) Liposome leakage assays monitoring the de-quenching of sulforhodamine B fluorescence as a function of time in the presence of WT MLKL(2–154) (black
curve), NSA (blue curve), andMLKL(2–154) that had been preincubated with NSA (red curve). In (A) and (C), proteins and/or NSAwere added after 200 s. The data
were normalized with the fluorescence observed after adding detergent, and setting at zero the fluorescence right before protein or NSA addition.
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Mechanism of Membrane Permeation by MLKLand have studied the molecular mechanism underlying the
membrane permeabilization activity. Our results suggest a plug
release mechanism whereby the four-helix bundle is responsible
for membrane permeation and helix H6 serves as a plug to inhibit
opening of the four-helix bundle and membrane insertion,
providing at the same time a link to couple phosphorylation of
the kinase-like domain to allosteric changes that activate the
membrane permeation activity.
The finding that the MLKL N-terminal domain permeabilizes
membranes and the prediction that this domain is formed by a
helices suggested a similarity with members of the Bcl-2 family
of apoptotic proteins that are also helical and permeabilizemem-
branes such Bax (Wei et al., 2001; Epand et al., 2002; Kuwana
et al., 2002). However, our solution structure of MLKL(2–154)
and the recently reported crystal structure of MLKL (Murphy
et al., 2013) show that the soluble, monomeric form of the
MLKL N-terminal is not structurally related to Bax, even though
it has a similar size and is also formed by a helices. Nevertheless,
this finding does not completely rule out the possibility that the
membrane permeabilization mechanisms of Bax and MLKL
might be similar. In the case of Bax, this mechanism has been
studied for many years but a consensus model has not yet
emerged, which emphasizes the difficulties involved in eluci-
dating how proteins form pores in membranes. Nevertheless,
crystal structures of Bax have provided key insights into its
activation mechanism, leading to a model whereby inhibitory in-the backbone, carbon atoms are in green, oxygen atoms are in red, nitrogen ato
bottom. Note the poor packing between helices H2 and H5 (D).
(E) Superposition of helices H2 and H5 from our solution structure of MLKL(2–15
chains are shown as stickmodels. The side chains ofW109 of our solution structur
their different orientations.
(F and G) Ribbon diagrams of helices H2 and H6 in our solution structure of ML
as stick models with oxygen atoms in red, nitrogen atoms in dark blue and carbo
two helices are labeled. Note that in H2 the residue numbers are the same for hom
in H6.
Structure 22, 1489–tramolecular interactions within Baxmust be released for its acti-
vation (Czabotar et al., 2013). This feature does resemble the
mechanism for MLKL activation proposed here.
Our NBD fluorescence experiments (Figure 5) provided key
data suggesting this mechanism. As mentioned above, the re-
sults obtained for each individual mutant need to be interpreted
with caution because themutations and NBD labeling could alter
intramolecular and intermolecular interactions that stabilize the
oligomeric pores formed by MLKL(2–154) in phospholipid bila-
yers. Indeed, themutations caused a range of effects on the abil-
ity of MLKL(2–154) to induce liposome leakiness (Figure S5),
which can arise from thermodynamic effects affecting the stabil-
ity of the MLKL oligomers in the membranes and/or from kinetic
effects caused by alteration of the rate of opening of the soluble,
monomeric MLKL(2–154). Nevertheless, the overall data ob-
tained from the NBD fluorescence experiments does provide a
clear picture whereby much of the four-helix bundle is respon-
sible for membrane insertion, whereas helix H6 does not insert
into the membrane. Importantly, this conclusion can be rational-
ized naturally from examination of our solution structure of the
MLKL N-terminal domain as well as from theMLKL crystal struc-
ture. Helices H1, H2, H3, and H5, which form the four-helix
bundle, are very amphipathic, with hydrophobic surfaces buried
inside the domain and highly charged surfaces exposed to the
solvent in the monomeric soluble form (Figures 6A–6D). Clearly,
the charged surfaces cannot be inserted into the hydrophobicms are in blue and sulfur atoms are in yellow. The helices are indicated at the
4) (blue) and the crystal structure of MLKL (orange; Murphy et al., 2013). Side
e and the homologous residue inmouseMLKL (W108) are labeled to emphasize
KL(2–154) (F) and in the crystal structure of MLKL (G). Side chains are shown
n atoms in lighter blue (F) or orange (G). Residues in the interface between the
ologous residues in the two structures, whereas they are shifted by one residue
1500, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1497
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between helices H2 and H5 provides a natural ‘‘weak’’ point
where the structure can open to expose the hydrophobic faces
of the helices for insertion into the bilayer. Intramolecular binding
of helix H6 to the groove between helices H2 and H5 is expected
to stabilize the overall structure of MLKL(2–154) and thus hinder
such opening of the structure. Further stabilization is likely pro-
vided by contacts of helix H6 with helix H4 at the top of the
domain (Figure 4B), which include packing of Phe148 against
C86 and other side chains of helix H4 (Figure S7C).
C86 is the residue of MLKL that reacts with the small molecule
NSA, which blocks necroptosis (Sun et al., 2012). The finding
that the liposome permeabilization activities of MLKL(2–154)
(Figure 7C) and full-length MLKL (Wang et al., 2014) are inhibited
by NSA indicate that the action of NSA in cells can be repro-
duced, at least to some extent, in the liposome leakage assays.
The effect of NSA in these assays is less drastic that the impair-
ment of necroptosis caused in cells (Sun et al., 2012), but it is
likely that the ‘‘threshold’’ for activation of MLKL in cells is
considerably higher because of a lower cellular concentration
of MLKL and/or because activation is hindered by interactions
with other factors within the necrosome. This view is supported
by the observation that, although mutations that mimic phos-
phorylation by RIP3 increase the liposome permeabilization ac-
tivity of MLKL, the WT protein already has some activity in this
assay, whereas phosphorylation of MLKL is required for necrop-
tosis in cells (Wang et al., 2014). The inhibition caused by NSA in
the liposome leakage assays suggests that the covalent modifi-
cation of C86 disrupts intra- or intermolecular interactions that
are critical for formation of pores within the membranes. Hence,
helix H6 likely acts as a plug that inhibits the membrane perme-
abilization activity not only by binding to the helix H2-helix H5
interface, but also through its interactions with helix H4.
Our model is supported by the finding that a MLKL fragment
containing the four-helix bundle but lacking helix H6 [MLKL(2–
123)] is much more active in the liposome leakage assays than
MLKL(2–154), and that mutation of two basic residues from helix
H2 that contact helix H6 also enhances the activity of MLKL(2–
154) in this assay (Figure 7A). Moreover, the MLKL four-helix
bundle is sufficient to trigger necroptosis (Chen et al., 2014).
The rest of the protein provides a natural mechanism to inhibit
this activity and to couple the RIP3 signal to activation, thus lead-
ing to necroptosis. Helix H6 appears to be key for such coupling
both because of its role as a plug that inhibits opening of the
four-helix bundle and because it provides a connection to the ki-
nase-like domain. The differences observed in the interactions
between helices H2 and H6 in our solution structure and the
crystal structure ofMLKL (Figures 6F and 6G) show that the inter-
face between H6 and the four-helix bundle is malleable and
hence can be altered through allosteric changes induced by
phosphorylation of the kinase-like domain. The fact that helix
H4 is observable in our solution structure of the isolated
MLKL(2–154) fragment but not in the crystal structure of MLKL
(Figure 4C) further shows that there are intimate contacts be-
tween the N-terminal domain and the kinase-like domain that
can be remodeled upon phosphorylation.
Clearly, much research will be necessary to further test our
model, including challenging high-resolution structural studies
of the MLKL four-helix bundle in membranes, and it remains to1498 Structure 22, 1489–1500, October 7, 2014 ª2014 Elsevier Ltd Abe seen whether themechanisms used byMLKL and Bax to per-
meabilize membranes are similar. Indeed, it would not be sur-
prising if these mechanisms are fundamentally different given
the lack of a clear structural similarity between their membrane
permeabilizing domains, and the fact that there are diverse
ways in which soluble proteins can insert into membranes to
form pores (e.g., Mukherjee et al., 2014). This work provides an
initial model and a framework to address these questions in
the future.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
DNA constructs for bacterial expression of human MLKL(2–123), MLKL(2–
154), and MLKL(2–178) were prepared from an original vector containing the
full-length human MLKL sequence (Sun et al., 2012) and cloned into a
pGEX-KG vector using standard recombinant DNA techniques. The different
mutations of MLKL(2–154) were made by site-directed mutagenesis using
the QuickChange site-directed mutagenesis kit (Stratagene). The proteins
were expressed in bacteria (Escherichia coli BL21) as GST fusion proteins, pu-
rified by affinity chromatography on glutathione-sepharose beads (GE Health-
care), cleaved with thrombin on beads, eluted with thrombin cleavage buffer
containing 50 mM Tris$HCl (pH 8.0)/150 mM NaCl/2.5 mM CaCl2, and further
purified by size-exclusion chromatography on an S75 Superdex column
(Amersham Biosciences) in a buffer containing 20 mM HEPES pH 7.4,
100 mMNaCl. For NMR studies, uniform 15N-labeling or 15N- and 13C-labeling
was achieved by growing bacteria in minimal medium containing 15NH4Cl or
with 15NH4Cl and [
13C6]glucose (CIL) as the sole nitrogen and carbon sources,
respectively.
NMR Spectroscopy
NMR spectra for structure determination were acquired on INOVA600 or
INOVA800 spectrometers at 25C using 1.5 mM samples of uniformly 15N-
labeled or 15N,13C-labeled MLKL(2–154) in buffer containing 20 mM HEPES
pH7.0, 100 mM NaCl, 2 mM Tris(2-carboxyethyl)phosphine, with 5% D2O.
Chemical shift assignments, NOEs, and amide protection data for structural
determination were obtained from a series of gradient enhanced 2D and 3D
experiments. These experiments included 3D 15N-edited total correlated
spectroscopy (TOCSY)-HSQC, 15N,13C-edited NOESY-HSQC, HNCO,
HNCACB, CBCA(CO)NH, H(C)(CO)NH-TOCSY, (H)C(CO)NH-TOCSY, and
HCCH-TOCSY spectra for backbone and nonaromatic side chain assign-
ments; and 2D aromatic constant time (CT) 1H13CHSQC, HBCBCGCDHD,
HBCBCGCDCEHE, DQF-COSY, TOCSY, and NOESY spectra for aromatic
side chain assignments (Zhang et al., 1994; Kay et al., 1993, 1994; Muhan-
diram and Kay, 1994; Kay, 1993). For 2D DQF-COSY, TCOSY, and NOESY
experiments, D2O was used as the solvent. The mixing time in NOESY exper-
iments was 100 ms. Protection of amide protons from the solvent was identi-
fied from the intensities of exchange cross-peaks with the water resonance
in 3D 1H15N NOESY-HSQC and TOCSY-HSQC experiments. Stereospecific
assignments of leucine and valine methyl groups were obtained from a 1H-13C
CT-HSQC spectrum acquired on a 1.5 mM sample of 10% 13C-labeled
MLKL(2–154). All data were processed with NMRPipe (Delaglio et al., 1995)
and analyzed with NMRView (Johnson and Blevins, 1994).
Structure Calculations
Distance restraints were derived from NOE cross-peak intensities. Restraints
of 1.8–2.8 A˚, 1.8–3.5 A˚, 1.8–5.0 A˚, and 1.8–6.0 A˚ were assigned to cross-
peak intensities classified as strong, medium, weak, and very weak, respec-
tively, with appropriate pseudoatom corrections using r6 averaging. Phi and
psi torsions angle restraints were generated with the program TALOS (Corni-
lescu et al., 1999). The restraints were centered at the values predicted by
TALOS ± the maximum of 22.5 or 1.5 times the SD observed in the TALOS
database matches. The hydrogen bond restraints were set 1.3–2.5 A˚ for
the H/O distances and 2.3–3.5 A˚ for the N/O distances. Structures of
MLKL(2–154) were initially calculated and refined using torsion angle simulated
annealing with the program CNS (Bru¨nger et al., 1998). A total of 4,000ll rights reserved
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Mechanism of Membrane Permeation by MLKLstructures were calculated with the final set of restraints, and the 20 structures
with the lowest NOE energy were selected.
Dye Leakage Assays
Liposomes with lipid composition of 45% 1-palmitoyl,2-oleoyl-sn-glycero-3-
phosphocholine (POPC), 30% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoe-
thanolamine (POPE), 10% phosphatidylinositol (PI), and 15% cardiolipin and
with 40 mM sulforhodamine B encapsulated were prepared basically as
described (Chen et al., 2006). Briefly, lipid mixtures dissolved in CHCL3 were
dried in a glass tube with nitrogen gas and further dried in a vacuum overnight.
The lipid films were first re-suspended in 400 ml buffer containing 20 mM
HEPES pH7.4, 100 mM NaCl, 40 mM sulforhodamine B by vortexing at least
5 min, and then frozen and thawed five times. The final lipid concentration
was 5 mM. Liposomes were formed by extruding the re-suspended lipid films
through an 80 nm polycarbonate filter with an Avanti extruder for at least 29
times. Liposomes and the free sulforhodamine B were then separated using
a PD10 column. For leakage assays, liposomes containing 150 mM lipids
were incubated without or with 2 mM WT or mutant MLKL fragments as indi-
cated in the figure legends, except for the titration experiments of Figure 3
where different concentrations of WT MLKL(2–154) were used. For the exper-
iments to test the effect of NSA on the liposome leakage activity of MLKL(2–
154), 100 mM 15N-labeled MLKL(2–154) was first incubated with 1 mM NSA
at room temperature for 2 hr in a buffer containing 20 mM HEPES pH 7.4,
100 mM NaCl, and 200 mmM TCEP. The completeness of the reaction with
NSA was confirmed by monitoring the 1H-15N HSQC spectra of the 15N-
labeled MLKL(2–154), which revealed shifts and/or broadening beyond detec-
tion of cross-peaks from residues near C86, as expected from the finding that
this cysteine residue is the target of NSA (Wang et al., 2014). Dye leakage of the
liposomes was measured by monitoring the fluorescence increase at 587 nm
(excitation at 565 nm) with a PTI spectrofluorometer. The distribution of lipo-
some sizes was analyzed by dynamic light scattering as described (Arac¸
et al., 2006).
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